Literature DB >> 12091208

Elevation of the cortisol-dehydroepiandrosterone ratio in drug-free depressed patients.

Allan H Young1, Peter Gallagher, Richard J Porter.   

Abstract

OBJECTIVE: Elevated basal cortisol levels are a feature of depressive illness and cause deficits in learning and memory. The adrenal steroid dehydroepiandrosterone (DHEA) has antiglucocorticoid properties that may offer protection against the deleterious effects of cortisol. The authors examined the ratio of cortisol to DHEA in drug-free depressed patients and a matched comparison group.
METHOD: Cortisol and DHEA were measured in saliva samples from 39 patients with unipolar depression who had been medication free for at least 6 weeks and 41 healthy comparison subjects.
RESULTS: The molar cortisol-DHEA ratio was significantly higher in the depressed patients than in the healthy comparison subjects. Cortisol-DHEA ratios from saliva samples taken at 8:00 p.m. correlated positively with length of current depressive episode.
CONCLUSIONS: Elevated cortisol-DHEA ratios may be a state marker of depressive illness and may contribute to the associated deficits in learning and memory. Administration of DHEA or other antiglucocorticoid treatments may reduce neurocognitive deficits in major depression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12091208     DOI: 10.1176/appi.ajp.159.7.1237

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  45 in total

1.  Habitual sleep quality and diurnal rhythms of salivary cortisol and dehydroepiandrosterone in postmenopausal women.

Authors:  Tianyi Huang; Elizabeth M Poole; Celine Vetter; Kathryn M Rexrode; Laura D Kubzansky; Eva Schernhammer; Nicolas Rohleder; Frank B Hu; Susan Redline; Shelley S Tworoger
Journal:  Psychoneuroendocrinology       Date:  2017-07-19       Impact factor: 4.905

Review 2.  Neurosteroid, GABAergic and hypothalamic pituitary adrenal (HPA) axis regulation: what is the current state of knowledge in humans?

Authors:  Shannon K Crowley; Susan S Girdler
Journal:  Psychopharmacology (Berl)       Date:  2014-04-23       Impact factor: 4.530

3.  Depressive symptoms and risk of uterine leiomyomata.

Authors:  Lauren A Wise; Se Li; Julie R Palmer; Lynn Rosenberg
Journal:  Am J Obstet Gynecol       Date:  2014-12-13       Impact factor: 8.661

4.  Increased salivary cortisol after waking in depression.

Authors:  Zubin Bhagwagar; Sepehr Hafizi; Philip J Cowen
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

5.  Diurnal patterns of salivary cortisol and DHEA using a novel collection device: electronic monitoring confirms accurate recording of collection time using this device.

Authors:  Mark L Laudenslager; Jacqueline Calderone; Sam Philips; Crystal Natvig; Nichole E Carlson
Journal:  Psychoneuroendocrinology       Date:  2013-03-13       Impact factor: 4.905

6.  Interaction between the BDNF gene Val/66/Met polymorphism and morning cortisol levels as a predictor of depression in adult women.

Authors:  J Herbert; M Ban; G W Brown; T O Harris; A Ogilvie; R Uher; T K J Craig
Journal:  Br J Psychiatry       Date:  2012-07-26       Impact factor: 9.319

7.  Day-to-day differences in cortisol levels and molar cortisol-to-DHEA ratios among working individuals.

Authors:  Min-Soo Kim; Young-Jin Lee; Ryun-Sup Ahn
Journal:  Yonsei Med J       Date:  2010-02-12       Impact factor: 2.759

8.  Glucocorticoid receptor dysfunction: consequences for the pathophysiology and treatment of mood disorders.

Authors:  Aju Abraham; Stuart Watson; Allan H Young
Journal:  Indian J Psychiatry       Date:  2003-04       Impact factor: 1.759

9.  Elevated prolactin responses to L-tryptophan infusion in medication-free depressed patients.

Authors:  Richard J Porter; Peter Gallagher; Stuart Watson; Margaret S Smith; Allan H Young
Journal:  Psychopharmacology (Berl)       Date:  2003-05-01       Impact factor: 4.530

10.  The effects of galantamine hydrobromide treatment on dehydroepiandrosterone sulfate and cortisol levels in patients with chronic fatigue syndrome.

Authors:  Tayfun Turan; Hasan Basri Izgi; Saliha Ozsoy; Fatih Tanrıverdi; Mustafa Basturk; Akif Asdemir; Aslı Beşirli; Ertugrul Esel; Seher Sofuoglu
Journal:  Psychiatry Investig       Date:  2009-06-23       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.